Retatrutide (LY3437943) is a first-in-class triple hormone receptor agonist developed by Eli Lilly
GLP-1 (Glucagon-like peptide-1) injections are a class of medications that mimic the action of the natural GLP-1 hormone in the body, stimulating insulin secretion, suppressing appetite, and delaying gastric emptying, thereby promoting weight loss
Treatment typically begins with a low dose, gradually increases, and then transitions to a semaglutide maintenance dose for weight loss and management
Ingredients: 2 celery stalks, cut into 3-inch sticks 1/4 avocado, mashed 4 slices deli turkey (look for low-sodium, nitrate-free options) Pinch of everything bagel seasoning or black pepper (optional) Instructions: Spread a thin layer of mashed avocado into the groove of each celery stick
Conflicting Data: While some clinical trials suggested a minor increase in risk, many large-scale "real-world" studies have found no statistically significant difference in pancreatitis risk when comparing GLP-1 users to those on other diabetes treatments
However, the difference isnt dramatic
